selected publications
-
academic article
-
Typing of vancomycin-resistant enterococci with MALDI-TOF mass spectrometry in a nosocomial outbreak setting.
Clinical Microbiology and Infection.
24.
2018
BMI‐1 protein expression as a negative independent prognostic factor in DLBCL.
Hematological Oncology.
35.
2017
Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark..
Journal of Antimicrobial Chemotherapy.
72.
2017
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
PLoS ONE.
12.
2017
Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
Journal of Clinical Microbiology.
56.
2017
Whole Genome Sequencing of Danish Staphylococcus argenteus Reveals a Genetically Diverse Collection with Clear Separation from Staphylococcus aureus.
Frontiers in Microbiology.
8.
2017
Danish National Lymphoma Registry.
Clinical Epidemiology.
Volume 8.
2016
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia & Lymphoma.
56.
2015
Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma.
Leukemia & Lymphoma.
56.
2015
Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.
Experimental Hematology.
43.
2015
Multiple hospital outbreaks of vanA Enterococcus faecium in Denmark, 2012–13, investigated by WGS, MLST and PFGE.
Journal of Antimicrobial Chemotherapy.
70.
2015
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood.
124.
2014
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non‐Hodgkin and Hodgkin lymphoma.
American Journal of Hematology.
89.
2014
-
dataset
-
Baseline clinical characteristics and treatment response in all patients and in patients treated with R-CHOP and R-CHOEP..
public-library-of-science.
2017
Baseline molecular characteristics in all patients and in patients treated with R-CHOP and R-CHOEP..
public-library-of-science.
2017
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
public-library-of-science.
2017
Univariate survival analyses in all patients and in patients treated with R-CHOP and R-CHOEP..
public-library-of-science.
2017